DK1556494T3 - Bicistronisk vektor, der koder en VEGF og en FGF, samt anvendelse deraf - Google Patents
Bicistronisk vektor, der koder en VEGF og en FGF, samt anvendelse derafInfo
- Publication number
- DK1556494T3 DK1556494T3 DK03754321T DK03754321T DK1556494T3 DK 1556494 T3 DK1556494 T3 DK 1556494T3 DK 03754321 T DK03754321 T DK 03754321T DK 03754321 T DK03754321 T DK 03754321T DK 1556494 T3 DK1556494 T3 DK 1556494T3
- Authority
- DK
- Denmark
- Prior art keywords
- fgf
- vegf
- well
- vector encoding
- bicistronic vector
- Prior art date
Links
- 239000013598 vector Substances 0.000 title abstract 2
- 102000005789 Vascular Endothelial Growth Factors Human genes 0.000 title 1
- 108010019530 Vascular Endothelial Growth Factors Proteins 0.000 title 1
- 239000002870 angiogenesis inducing agent Substances 0.000 abstract 1
- 230000002491 angiogenic effect Effects 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 210000004204 blood vessel Anatomy 0.000 abstract 1
- 238000001415 gene therapy Methods 0.000 abstract 1
- 238000001727 in vivo Methods 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 239000013600 plasmid vector Substances 0.000 abstract 1
- 230000028327 secretion Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1858—Platelet-derived growth factor [PDGF]
- A61K38/1866—Vascular endothelial growth factor [VEGF]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
- A61K48/005—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy characterised by an aspect of the 'active' part of the composition delivered, i.e. the nucleic acid delivered
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- C07K14/50—Fibroblast growth factor [FGF]
- C07K14/503—Fibroblast growth factor [FGF] basic FGF [bFGF]
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/036—Fusion polypeptide containing a localisation/targetting motif targeting to the medium outside of the cell, e.g. type III secretion
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Genetics & Genomics (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Animal Behavior & Ethology (AREA)
- Gastroenterology & Hepatology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Biophysics (AREA)
- Vascular Medicine (AREA)
- Epidemiology (AREA)
- Toxicology (AREA)
- Biochemistry (AREA)
- Heart & Thoracic Surgery (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Urology & Nephrology (AREA)
- Cardiology (AREA)
- Biotechnology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Immunology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Compression, Expansion, Code Conversion, And Decoders (AREA)
- Ultra Sonic Daignosis Equipment (AREA)
- Compression Of Band Width Or Redundancy In Fax (AREA)
- Medicines Containing Plant Substances (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
PL355354A PL195457B1 (pl) | 2002-08-05 | 2002-08-05 | Kaseta ekspresyjna, dwucistronowy wektor plazmidowy, środek farmaceutyczny oraz ich zastosowanie |
PCT/PL2003/000076 WO2004012775A2 (en) | 2002-08-05 | 2003-08-05 | Bicistronic vector encoding a vegf and an fgf, use thereof |
Publications (1)
Publication Number | Publication Date |
---|---|
DK1556494T3 true DK1556494T3 (da) | 2007-12-03 |
Family
ID=31492970
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
DK03754321T DK1556494T3 (da) | 2002-08-05 | 2003-08-05 | Bicistronisk vektor, der koder en VEGF og en FGF, samt anvendelse deraf |
Country Status (7)
Country | Link |
---|---|
EP (1) | EP1556494B1 (da) |
AT (1) | ATE368745T1 (da) |
AU (1) | AU2003272159A1 (da) |
DE (1) | DE60315330T2 (da) |
DK (1) | DK1556494T3 (da) |
PL (1) | PL195457B1 (da) |
WO (1) | WO2004012775A2 (da) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1318594C (zh) * | 2005-03-02 | 2007-05-30 | 首都医科大学 | 重组人VEGF与bFGF真核表达载体、融合蛋白及其用途 |
CN100564527C (zh) * | 2006-10-23 | 2009-12-02 | 中国人民解放军军事医学科学院生物工程研究所 | A型肉毒毒素受体结合区Hc基因及其编码蛋白与应用 |
Family Cites Families (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6121246A (en) * | 1995-10-20 | 2000-09-19 | St. Elizabeth's Medical Center Of Boston, Inc. | Method for treating ischemic tissue |
NZ510121A (en) * | 1998-10-26 | 2003-02-28 | Licentia Ltd | Use of VEGF-C or VEGF-D gene or protein to prevent restenosis of blood vessels |
CA2350226C (en) * | 1998-11-20 | 2012-04-24 | Fuso Pharmaceutical Industries, Ltd. | Protein expression vector and utilization thereof |
DE19910419A1 (de) * | 1999-03-10 | 2000-09-21 | Aventis Pharma Gmbh | Zielzellspezifische, multivalente Proteine (MVP) |
US20020115202A1 (en) * | 1999-08-13 | 2002-08-22 | Paul Hallenbeck | Adenoviral vectors including dna sequences encoding angiogenic inhibitors |
NZ546670A (en) * | 1999-11-05 | 2009-02-28 | Univ California | Techniques and compositions for treating cardiovascular disease by in vivo gene delivery |
WO2001081544A2 (en) * | 2000-04-25 | 2001-11-01 | The Board Of Regents Of The University Of Oklahoma | Identification and uses of a hyaluronan receptor |
-
2002
- 2002-08-05 PL PL355354A patent/PL195457B1/pl not_active IP Right Cessation
-
2003
- 2003-08-05 AT AT03754321T patent/ATE368745T1/de not_active IP Right Cessation
- 2003-08-05 EP EP03754321A patent/EP1556494B1/en not_active Expired - Lifetime
- 2003-08-05 DK DK03754321T patent/DK1556494T3/da active
- 2003-08-05 DE DE60315330T patent/DE60315330T2/de not_active Expired - Lifetime
- 2003-08-05 AU AU2003272159A patent/AU2003272159A1/en not_active Abandoned
- 2003-08-05 WO PCT/PL2003/000076 patent/WO2004012775A2/en active IP Right Grant
Also Published As
Publication number | Publication date |
---|---|
PL195457B1 (pl) | 2007-09-28 |
EP1556494B1 (en) | 2007-08-01 |
DE60315330D1 (de) | 2007-09-13 |
PL355354A1 (en) | 2004-02-09 |
DE60315330T2 (de) | 2008-05-08 |
AU2003272159A8 (en) | 2004-02-23 |
ATE368745T1 (de) | 2007-08-15 |
WO2004012775A3 (en) | 2004-05-27 |
WO2004012775A2 (en) | 2004-02-12 |
EP1556494A2 (en) | 2005-07-27 |
AU2003272159A1 (en) | 2004-02-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MXPA05008406A (es) | Compuestos de amida tri(ciclo)-sustituida. | |
WO2003093418A3 (en) | Keratinocytes expressing exogenous angiogenic growth factors | |
IL156264A0 (en) | Isoindolin-1-one glucokinase activators | |
IL175158A0 (en) | Tocopherol-modified therapeutic drug compounds | |
AP1763A (en) | Pulmonary administration of chemically modified insulin | |
WO2003002069A3 (en) | Intradermal delivery of vaccines and gene therapeutic agents via microcannula | |
CY1110547T1 (el) | Συμπυκνωμενα πρωτεϊνικα σκευασματα μειωμενου ιξωδους | |
AU2001294096A1 (en) | Adeno-associated virus-mediated delivery of angiogenic factors | |
EP1259240B8 (en) | Agents, such as nicotinamide or cadpr for the treatment of skin disorders | |
AU2002213698A1 (en) | Needleless syringe for the subcutaneous delivery of therapeutic agents | |
CY1110182T1 (el) | Ιδεβενονη για τη θεραπεια των μυϊκων δυστροφιων | |
ATE512668T1 (de) | Allogenes tumortherapeutikum | |
TW200626137A (en) | Preventive or therapeutic agent for sleep disorder | |
IL145069A0 (en) | Pharmaceutical compositions for delivery to an external wall of a body passageway or cavity | |
EP1663377A4 (en) | THERAPEUTIC MEDICAL DEVICE, DELIVERY AND METHOD OF USE | |
EP1542672A4 (en) | R-BAMBUTEROL, ITS PREPARATION AND THERAPEUTIC USES | |
DK1372770T3 (da) | Forbedringer til og angående en injektionsanordning | |
DK1556494T3 (da) | Bicistronisk vektor, der koder en VEGF og en FGF, samt anvendelse deraf | |
NO20061542L (no) | P185neu-Kodende DNA samt terapeutiske anvendelser derav | |
HUP0400340A2 (hu) | Polipeptidek immunogenitásának csökkentésére szolgáló eljárások | |
GB0710457D0 (en) | Vegf Mutants | |
WO2005018569A3 (en) | Compositions of a cyclooxygenase-2 selective inhibitor and a serotonin modulating agent for the treatment of neoplasia | |
MY151447A (en) | Intravenous injection of non-neurotoxic plasminogen activators for the treatment of stroke | |
MXPA04004763A (es) | Esteres dobles. | |
Brooks | What's love got to do with it? |